NCT00509288 Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Infusion of Anti-MART-1 F5 TCR-Gene-Engineered Lymphocytes Status COMPLETED Phase PHASE2
NCT00507442 Phase 1/2 Study of VELCADE® in Combination With Other Drugs to Treat Previously Untreated Multiple Myeloma Patients Status COMPLETED Phase PHASE1/PHASE2
NCT00505921 Autologous and Allogenic Transplantation With Campath-1H for T-Cell Lymphoma Status TERMINATED Phase PHASE2
NCT00501826 Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Status RECRUITING Phase PHASE2
NCT00499733 Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer Status TERMINATED Phase EARLY_PHASE1
NCT00499616 Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma Status COMPLETED Phase PHASE3
NCT00499603 Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer Status UNKNOWN Phase PHASE2
NCT00499122 NOV-002, Doxorubicin, Cyclophosphamide, and Docetaxel in Women With Newly Diagnosed Stage II or IIIC Breast Cancer Status COMPLETED Phase PHASE2
NCT00499083 Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women) Status COMPLETED Phase PHASE2
NCT00496665 ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast Cancer Status COMPLETED Phase PHASE1
NCT00494897 PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE4
NCT00494780 Ofatumumab (Humax-CD20) With CHOP (Cyclophosphamide,Doxorubicin, Vincristine, Predisolone) in Follicular Lymphoma (FL) Patients Status COMPLETED Phase PHASE2
NCT00490529 Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL Status COMPLETED Phase PHASE2
NCT00489281 Non-Myeloablative Bone Marrow Transplant for Patients With Sickle Cell Anemia and Other Blood Disorders Status TERMINATED Phase PHASE2
NCT00486668 A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer Status UNKNOWN Phase PHASE3
NCT00483119 Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus Status TERMINATED Phase PHASE2